Announcements Trials
Browse Landscape

Phase

Phase 2 130Phase 1 66Phase 1/2 40Phase 3 34Phase NA 6Phase EARLY_PHASE1 6Phase 4 5Phase 2/3 3

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 5Thyroid Neoplasms 1Patient Acceptance of Health Care 1Ovarian Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × palbociclib × Clear all
NCT07487129 2026-03-23

Clinical and P

Beni-Suef University

Phase 4 Completed
206 enrolled
Breast

Breast Neoplasms

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed
130 enrolled
Breast

Breast Neoplasms, Patient Acceptance of Health Care

NCT05949424 2023-11-29

OPTI-DOSE

University Medical Center Groningen

Phase 4 Unknown
30 enrolled
BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT02679755 2022-07-27

Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer

Pfizer

Phase 4 Completed
252 enrolled 15 charts
Breast

Breast Neoplasms

NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡